Maria Angelo-Khattar PhD
Managing Director - Aesthetica Clinic Oasis
Dr. Angelo-Khattar obtained her B.Sc. Honours
and Ph.D. from King's College and St. Mary's Hospital Medical School,
University of London. She is a fellow of Royal Society of Medicine,
1977-1990 served as Assistant and then Associate Professor at the Department
of Pharmacology and Toxicology at the Faculty of Medicine, University
of Kuwait. In 1984, Dr. Khattar established the Toxicology Unit, a joint
venture between the Ministry of Health and the Faculty of Medicine,
Kuwait Univeristy. The unit offered a comprehensive analytical services
to all Ministry of Health Hospitals including Therapeutic Drug Monitoring,
Drug Abuse screening and Toxicological Screening in cases of acute poisoning.
The Toxicology Unit in Kuwait was the only one of its kind in the Middle
East, at the time.
Dr. Khattar has published 40 papers in International journals and left
Academia in 1990 during the Gulf War. She was reinstated in 1991as visiting
Associate Professor at the Faculty of Medicine, Kuwait University for
a period of 18 months, following which she was obliged to relocate to
1998 Dr. Khattar started a Business in retail Pharmacy in the United
Arab Emirates, which is now the Lifestyle chain of Pharmacies.
2002 Dr. Khattar established Aesthetica Clinic, dedicated to non-surgical
skin refinement and rejuvenation as well as Aesthetica Drug Store which
specialises in the trading of Dermo-cosmeceutical products and Isolagen,
the autologous fibroblast transfer treatment.
2012 - Fractional Ablative Lasers and Micro-plasma Radiofrequency in Skin Rejuvenation
Ablative laser resurfacing remains the “Gold Standard” for skin rejuvenation but is associated with long term patient downtime. Recently, fractional ablative technologies have been introduced including lasers such as the Erbium YAG and Carbon- dioxide lasers as well as a novel unipolar micro-plasma radiofrequency device, all of which have a unique mechanism of action that repairs a fraction of the skin at a time. Irrespective of the modality used in the fractional system, the primary target is both the epidermis and the dermis with the aim of creating small zones of microdamage separated by zones of un-irradiated tissue that assist with a rapid healing process. The simultaneous resurfacing of columns of the epidermis and upper dermis as well as the heating of the upper dermis to form new collagen, have a powerful skin rejuvenating effect with a relatively short down-time of five to seven days. The profound regenerative effects of these technologies are currently routinely used for the overall improvement in skin texture including the reduction of fine lines and wrinkles, the decrease in pore size, the treatment of post acne atrophic scarring and dyschromias as well as the treatment of burn scars.
The efficacy of ablative fractional resurfacing has recently been enhanced by the advent of a new ultrasound technology to boost the transdermal delivery of dermo-cosmeceuticals and growth factors via the microperforations produced by the fractional technology.
The presentation will review the unique features of the various treatment options employed for ablative fractional resurfacing with an emphasis on a novel ablative unipolar micro-plasma technology and the ultrasound- assisted post ablation dermo-cosmeceutical delivery for skin refining.